Clinical trial

Study of Ascending Levels of Tolvaptan in Hyponatremia

NCT00201994

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Tolvaptan Normalized identity: tolvaptanView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Ascending Levels of Tolvaptan in Hyponatremia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-11-01

PhasePHASE3

Conditions

Hyponatremiaunresolved

Interventions

TolvaptanDRUG · verified · RxNorm: tolvaptan

PlaceboDRUG

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Otsuka Pharmaceutical Co., Ltd.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00201994 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.